Show simple item record

dc.contributor.authorEtievant, Sibyle et al.
dc.date.accessioned2020-05-18T18:57:07Z
dc.date.available2020-05-18T18:57:07Z
dc.date.issued2020-05-04
dc.identifier.urihttps://doi.org/10.1101/2020.05.03.20072207en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/1540
dc.description.abstractThe sensitivity of SARS-CoV-2 RT-PCR tests developed by Charite (Germany), HKU (Hong-Kong), China CDC (China), US CDC (United-States), and Institut Pasteur, Paris (France) was assessed on SARS-CoV-2 cell culture supernatants and clinical samples. Although all RT-PCR assays performed well for SARS-CoV-2 detection, RdRp Institut Pasteur (IP2, IP4), N China CDC, and N1 US CDC were found to be the most sensitive.en_US
dc.languageEnglishen_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectInfectious Diseasesen_US
dc.subjectSARS-CoVen_US
dc.subjectCell Culture Techniquesen_US
dc.subjectPolymerase Chain Reactionen_US
dc.titleSensitivity assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratoriesen_US
eihealth.countryRegional, Americas (PAHO/OPS)en_US
eihealth.categoryVirus: natural history, transmission and diagnosticsen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySlow Spread / Reducir la Dispersiónen_US
dc.relation.ispartofjournalmedRxiven_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record